Inhibitors of human immunodeficiency virus type 1 derived from gp41 transmembrane protein: Structure-activity studies

Journal of Medicinal Chemistry

Volumn 39, Issue 14, 1996, Pages 2681-2689

  Kazmierski, Wieslaw M ^a   Hazen, Richard J ^a   Aulabaugh, Ann ^a   StClair, Marty H ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG ANALOG; GLYCOPROTEIN GP 41; LEUCINE ZIPPER PROTEIN; MEMBRANE PROTEIN; MYRISTIC ACID DERIVATIVE;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; DIASTEREOISOMER; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

ALANINE; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; CELL LINE; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PEPTIDE FRAGMENTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029956143     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950709u     Document Type: Article

References (46)

1. (a) Romero, D. L. HIV Reverse Transcriptase Inhibitors. In Annual Reports in Medicinal Chemistry; Bristol, J. A., Ed.; Academic Press: New York, 1994; Vol. 29, pp 123-132.
2. (b) Thaisrivongs, S. HIV Protease Inhibitors. In Annual Reports in Medicinal Chemistry; Bristol, J. A., Ed.; Academic Press: New York, 1994; Vol. 29, pp 133-144.
3. O'Brien, C. HIV Integrase Structure Catalyzes Drug Search. Science 1994, 266, 1946.
4. Boehme, R. E.; Borthwick, A. D.; Wyatt, P. G. Antiviral Agents. In Annual Reports in Medicinal Chemistry; Bristol, J. A., Ed.; Academic Press: New York, 1995; Vol. 30, pp 139-149.
5. Wild, C.; Greenwell, T.; Matthews, T. A Synthetic Peptide from HIV-1 gp41 is a Potent Inhibitor of Virus-Mediated Cell-Cell Fusion. AIDS Res. Hum. Retroviruses 1993, 9, 1051-1053.
6. Wild, C. T.; Shugars, D. C.; Greenwell, T. K.; McDanal, C. B.; Matthews, T. J. Peptides Corresponding to a Predictive α-Helical Domain of Human Immunodeficiency Virus Type 1 gp41 are Potent Inhibitors of Virus Infection. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 9770-9774.
7. Cao, J.; Bergeron, L.; Helseth, E.; Thali, M.; Repke, H.; Sodroski, J. Effects of Amino Acids Changes in the Extracellular Domain of the Human Immunodeficiency Virus Type I gp41 Envelope Glycoprotein. J. Virol. 1993, 67, 2747-2755.
8. Kowalski, M.; Potz, J.; Basiripour, L.; Dorfman, T.; Goh, W. C.; Terwilliger, E.; Dayton, A.; Rosen, C.; Haseltine, W.; Sodroski, J. Functional Regions of the Envelpe Glycoprotein of Human Immunodeficiency Virus type 1. Science 1987, 237, 1351-1355.
9. Kowalski, M.; Bergeron, L.; Dorfman, T.; Haseltine, W.; Sodroski, J. Attenuation of Human Immunodeficiency Virus Type I Cytophatic Effect by a Mutation Affecting the Transmembrane Envelope Glycoprotein. J. Virol. 1991, 65, 281-291.
10. Bergeron, L.; Sullivan, N.; Sodroski, J. Target Cell-Specific Determinants of Membrane Fusion within the Human Immunodeficiency Virus Type 1 gp120 Third Variable Region and gp41 amino teminus. J. Virol. 1992, 66, 2389-2397.
11. Wild, C.; Oas, T.; McDanal, C.; Bolognesi, D.; Matthews, T. A. Synthetic Peptide Inhibitor of Human Immunodeficiency Virus Replication: Correlation Between Solution Structure and Viral Inhibition. Proc. Natl. Acad. Sci. U.SA. 1992, 89, 10537-10541.
12. Lau, S. Y. M.; Taneja, A. K.; Hodges, R. S. Synthesis of a Model Protein of Defined Secondary and Quaternary Structure. J. Biol. Chem. 1984, 259, 13253-13261.
13. Rozelle, J. E., Jr.; Erickson, B. W. Synthesis and Characterization of a Three-Heptad Coiled-Coil Protein. In PEPTIDES: Chemistry, Structure, & Biology; Hodges, R. S., Smith, J. A., Eds.; ESCOM: Leiden, 1994; pp 1065-1066.
14. (a) Kazmierski, W. M.; McDermed, J. D. A New Method for Defining Dimerization Interfaces in Proteins. In Peptides: Chemistry, Structure & Biology; Hodges, R. S., Smith, J. A., Eds.; ESCOM: Leiden, 1994; pp 1045-1047.
15. (b) Kazmierski, W. M.; McDermed, J. Disruption of Helix-Helix Interactions in Biologically Relevant Proteins. HIV-1 Inhibition by gp41 Fragments. In Peptides 1994; ESCOM: Leiden, 1995; pp 52-53.
16. (c) Kazmierski, W. M.; McDermed, J.; Aulabaugh, A. A New Experimental method to Determine the Mutual Orientation of Helices in Coiled-Coil Proteins: Structural Information about the Dimeric Interface of cJun, cFos, GCN4 and gp41. Chem. Eur. J. 1996, 2, 403-411.
17. Kazmierski, W. M. Recent Advances in the Design and Synthesis of Small-Molecule Mimetic Drugs. Trends Biotechnol. 1994, 12, 216-218.
18. Gaudreau, P.; Brazeau, P.; Richer, M.; Cormier, J.; Langlois, D.; Langelier, Y. Structure-Function Studies of Peptides Inhibiting the Ribonucleotide Reductase Activity of Herpes Simplex Virus Type I. J. Med. Chem. 1992, 35, 346-350.
19. (a) Fisher, A.; Yang, F.-D.; Rubin, H.; Cooperman, B. S. R2 C-Terminal Peptide Inhibition of Mammalian and Yeast Ribonucleotide Reductase. J. Med. Chem. 1993, 36, 3859-3862.
20. (b) Liuzzi, M.; Deziel, R.; Moss, N.; Beaulieu, P.; Bonneau, A.-M.; Bousquet, C.; Chafouleas, J. G.; Garneau, M.; Jaramillo, J.; Krogsrud, R. L.; Lagace, L.; McCollum, R. S.; Nawoot, S.; Guindon, Y. A Potent Peptidomimetic Inhibitor of HSV Ribonucleotide Reductase with Antiviral Activity in vivo. Nature 1994, 372, 695-698.
21. Lin, T. H.; Grandgenett, D. P. Retrovirus Integrase: Identification of a Potential Leucine Zipper Motif. Protein Eng. 1991, 4, 435-441.
22. Jacobo-Molina, A.; Ding, J.; Nanni, R. G.; Clark, A. D., Jr.; Lu, X.; Tantillo, C.; Williams, R. L.; Kamer, G.; Ferris, A. L.; Clark, P.; Hizi, A.; Hughes, S. H.; Arnold, E. Crystal Structure of Human Immunodeficiency Virus Type I Reverse Transcriptase Complexed with Double-Stranded DNA at 3.0 A Resolution Shows Bent DNA. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 6320-6324.
23. (a) Dutia, B. M.; Frame, M. C.; Subak-Sharpe, J. H.; Clark, W. N.; Marsden, H. S. Specific Inhibition of Herpesvirus Ribonucleotide Reductase by Synthetic Peptides. Nature 1986, 321, 439-441.
24. (b) Chung, T. D.; Luo, J.; Wymer, J. P.; Smith, C. C.; Aurelian, L. Leucine Repeats in the Large Subunit of Herpes Simplex Virus Type 2 Ribonucleotide Reductase (RR; ICP10) are Involved in RR Activity and Subunit Complex Formation. J. Gen. Virol. 1991, 72, 1139-1144.
25. Flemington, E.; Speck, S. H. Evidence for Coiled-Coil Dimer Formation by an Epstein-Barr Virus Transactivator that Lacks a Heptad Repeat of Leucine Residues. Proc. Natl. Acad. Sci. U.S.A. 1993, 87, 9459-9463.
26. Koch, W. J.; Inglese, J.; Stone, W. C.; Lefkowitz, R. J. The Binding Site for the beta gamma Subunits of heterotrimeric G proteins on the beta-Adrenergic Receptor Kinase. J. Biol. Chem. 1993, 268, 8256-8260.
27. Gallaher, W. R.; Ball, J. M.; Garry, R. F.; Griffin, M. C.; Montelaro, R. C. A General Model for the Transmembrane Proteins of HIV and Other Retroviruses. AIDS Res. Hum. Retroviruses 1989, 5, 431-440.
28. Srinivas, R. V.; Venkatachalapathi, Y. V.; Rui, Z.; Owens, R. J.; Gupta, K. B.; Srinivas, S. K.; Anantharamaiah, G. M.; Segrest, J. P.; Compans, R. W. Inhibition of Virus-Induced Cell Fusion by Apolipoprotein A-I and Its Amphiphatic Peptide Analogs. J. Cell. Biochem. 1991, 45, 224-237.
29. Chen, Y.-H.; Yang, J. T.; Chau, K. H. Determination of the Helix and β form of Proteins in Aqueous Solution by Circular Dichroism. Biochemistry 1974, 13, 3350-3359.
30. (a) Jackson, D. Y.; King, D. S.; Chmielewski, J.; Singh, S.; Schultz, P. G. General Approach to the Synthesis of Short α-helical Peptides. J. Am. Chem. Soc. 1991, 113, 9391-9392.
31. (b) Horwell, D. C.; Howson, W.; Nolan, W. P.; Ratcliffe, G. S.; Rees, D. C.; Willems, H. M. G. The Design of Dipeptide Helical Mimetics, Part I: the Synthesis of 1,6-Disubstituted Indanes. Tetrahedron 1995, 51, 203-216.
32. (c) McClure, K. F.; Renold, P.; Kemp, D. S. An Improved Synthesis of a Template for α-Helix Formation. J. Org. Chem. 1995, 60, 454-457.
33. t Protected Amino Acids Incorporating Aminodiacetic Acid Moiety. Tetrahedron Lett. 1993, 34, 4493-4496.
34. (e) Kazmierski, W. M. Efficient Synthesis of Metal Binding Peptides Incorporating Aminodiacetic Acid Based Ligands. Int. J. Pept. Protein Res. 1995, 45, 241-247.
35. Askew, B.; Ballester, P.; Buhr, C.; Jeong, K. S.; Jones, S.; Parris, K.; Williams, K.; Rebek, J., Jr. Molecular Recognition with Convergent Functional Groups. 6. Synthetic and Structural Studies with a Model Receptor for Nucleic Acid Components. J. Am. Chem. Soc. 1989, 111, 1082-1090.
36. Landshulz, W. H.; Johnson, P. F.; McKnight, S. L. The Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins. Science 1988, 240, 1759-1764.
37. Su, J. Y.; Hodges, R. S.; Kay, C. M. Effect of Chain Length on the Formation and Stability of Synthetic α-Helical Coiled-Coils. Biochemistry 1994, 33, 15501-15510.
38. Hruby, V. J.; Al-Obeidi, F.; Kazmierski, W. M. Emerging Approaches in the Molecular Design of Receptor Selective Peptide Ligands: Conformational,Topographical and Dynamic Considerations. Biochem. J. 1990, 268, 249-262.
39. Pinter, A.; Honnen, W. J.; Tilley, S. A.; Bona, C.; Zaghouani, H.; Gorny, M. K.; Zolla-Pazner, S. Oligomeric Structure of gp41, the Transmembrane Protein of Human Immunodeficiency Virus Type 1. J. Virol. 1989, 63, 2674-2679.
40. Thomas, D. J.; Wall, J. S.; Hainfeld, J. F.; Kaczorek, M.; Booy, F. P.; Trus, B. L.; Eiserling, F. A.; Steven, A. C. Gp160, the Envelope Glycoprotein of Human Immunodeficiency Virus Type 1, is a Dimer of 125-kilodalton Subunits Stabilized Through Interactions Between their gp41 Domains. J. Virol. 1991, 65, 3797-3803.
41. Greenberg, W. A.; Dervan, P. B. Energetics of Formation of Sixteen Triple Helical Complexes Which Vary at a Single Position within a Purine Motif. J. Am. Chem. Soc. 1995, 117, 5016-5022.
42. Henderson, L. A.; Qureshi, M. N. A Peptide Inhibitor of Human Immunodeficiency Virus Infection Binds to Novel Human Cell Surface Polypeptides. J. Biol. Chem. 1993, 268, 15291-15297.
43. Qureshi, N. M.; Coy, D. H.; Garry, R. F.; Henderson, L. A. Characterization of a Putative Cellular Receptor for HIV-1 Transmembrane Glycoprotein Using Synthetic Peptides. AIDS 1990, 4, 553-558.
44. Chen, C.-H.; Matthews, T. J.; McDanal, C. B.; Bolognesi, D. P.; Greenberg, M. L. A Molecular Clasp in the Human Immunodeficiency Virus (HIV) Type 1 TM Protein Determines the Anti-HIV Activity of gp41 Derivatives: Implication for Viral Fusion. J. Virol. 1995, 69, 3771-3777.
45. (a) Kazmierski, W. M.; Hurley, K. New Reagent for the Affinity Purification of Peptides. In Peptides:Chemistry, Structure & Biology; Kaumaya, P. T. P., Hodges, R. S., Eds.; ESCOM: Leiden, 1995; in press.
46. (b) Kazmierski, W. M.; McDermed, J. Synthesis of the Carbonic Acid Benzotriazol-1-yl-Ester-(2-Biotinylamino)-9H-Fluoren-9-ylmethyl Ester: A Convenient Transient-Biotinylation Reagent for Use in Affinity Chromatography. Tetrahedron Lett. 1996, 36, 9097-10000.